Topic: Policy: Gene Therapies

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value 

Policy Paper

This white paper was developed following a December 2016 meeting of ICER’s membership program, during which leaders from 20 payer and manufacturer organizations convened to share their perspectives on the future of gene therapy. The paper explores the scientific frontier being opened up by emerging gene therapies, with the potential for curing or substantially improving the […]